Skip to main content

Clifford Chance

Clifford Chance


Healthcare & Life Sciences Update: The Netherlands - April 2014

23 April 2014

Companies active in the Dutch healthcare & life sciences sector are facing increasing compliance challenges: from ongoing changes to advertising rules and broadened enforcement of healthcare laws to increased attention for product classification and upcoming transparency requirements for medical devices. Pharmaceutical and medical devices companies in the Netherlands need to make sure that compliance with laws and regulations is at the forefront of their business planning. This Healthcare & Life Sciences Update highlights certain recent healthcare regulatory developments.

Download PDF